Article Figures & Data
Figures
- Figure 1.
Swefot: Rates of Achieving Primary Outcome (EULAR Good Response) by Treatment
EULAR=European League Against Rheumatism; Swefot=Swedish Farmacotherapy.
Reproduced from van Vollenhoven RF et al. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial. Lancet 2009;374(9688):459–466. With permission from Elsevier.
Tables
Tools
Table of contents
Cited By...
- No citing articles found.